Literature DB >> 32159771

Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics: A Report From the National Academies of Sciences, Engineering, and Medicine.

Sandra A Springer1, Andrew P Merluzzi2, Carlos Del Rio3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32159771      PMCID： PMC7957328          DOI： 10.1001/jama.2020.2559

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.

Authors:  Asher J Schranz; Aaron Fleischauer; Vivian H Chu; Li-Tzy Wu; David L Rosen
Journal:  Ann Intern Med       Date:  2018-12-04       Impact factor: 25.391

2.  Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver.

Authors:  Kevin Fiscella; Sarah E Wakeman; Leo Beletsky
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

3.  Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017.

Authors:  Mark Olfson; Lauren M Rossen; Melanie M Wall; Debra Houry; Carlos Blanco
Journal:  JAMA       Date:  2019-12-17       Impact factor: 56.272

4.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

5.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

6.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

Authors:  Jon E Zibbell; Alice K Asher; Rajiv C Patel; Ben Kupronis; Kashif Iqbal; John W Ward; Deborah Holtzman
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308
  6 in total
  4 in total

1.  Universal screening for hepatitis C virus infection should be linked to universal treatment access.

Authors:  Gregory J Dore; Gail V Matthews
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06       Impact factor: 46.802

2.  Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.

Authors:  Nikhil Seval; Cynthia A Frank; Alain H Litwin; Prerana Roth; Meredith A Schade; Martina Pavlicova; Frances R Levin; Kathleen T Brady; Edward V Nunes; Sandra A Springer
Journal:  Contemp Clin Trials       Date:  2021-04-07       Impact factor: 2.261

Review 3.  A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes.

Authors:  Katelyn F McNamara; Breanne E Biondi; Raúl U Hernández-Ramírez; Noor Taweh; Alyssa A Grimshaw; Sandra A Springer
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835

Review 4.  Lessons Learned from the Response to the Human Immunodeficiency Virus Epidemic that Can Inform Addressing the Opioid Epidemic.

Authors:  Sandra A Springer; Carlos Del Rio
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.